Scotiabank initiated coverage on Viking Therapeutics with a new price target
$VKTX
Biotechnology: Pharmaceutical Preparations
Health Care
Scotiabank initiated coverage of Viking Therapeutics with a rating of Sector Outperform and set a new price target of $102.00